Antimicrobial resistance of nosocomial strains of Staphylococcus aureus in Russia: Results of a prospective study

Journal of Chemotherapy

Volumn 17, Issue 1, 2005, Pages 54-60

  Stratchounski, L S ^a   Dekhnich, A V ^a   Kretchikov, V A ^a   Edelstain, I A ^a   Narezkina, A D ^a   Afinogenov, G E ^b   Akhmetova, L I ^c   Boronina, L G ^d   Gugutcidze, E N ^e   Gudkova, L V ^f   Zdzitovetcki, D E ^g   Ilyina, V N ^h   Kretchikova, O I ⁱ   Marusina, N E ^j   Multih, I G ^k   Pylaeva, S I ^l   Smirnov, I V ^m   Suborova, T N ⁿ   Taraban, V K ^o   Furletova, N M ^p   Hasanova, S G ^q   Schetinin, E V ^r   more..

^a Institute of Antimicrobial Chemotherapy   (Russian Federation)

^b All Russ Res Institut   (Russian Federation)

^c Diagn Ctr for Lab Diagnostics   (Russian Federation)

^d Regional Clinical Hospital   (Russian Federation)

^e Dept of the Pres of Russ Fed   (Russian Federation)

^f Regional Clinical Hospital   (Russian Federation)

^g Emergency Hospital   (Russian Federation)

^h Regional Cancer Clinic   (Russian Federation)

ⁱ Smolensk Reg Ctr Epidemiol Hyg   (Russian Federation)

^j Children s Republican Clinical Hospital   (Russian Federation)

^k Clinical Diagnostic Centre   (Russian Federation)

^l PRIVOLZHSKY RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^m RYAZAN STATE MEDICAL UNIVERSITY   (Russian Federation)

ⁿ Academy of Military Medicine   (Russian Federation)

^o Regional Clinical Hospital   (Russian Federation)

^p Speransky City Children's Clinical Hospital No 9   (Russian Federation)

^q City Clinical Hospital No21   (Russian Federation)

^r STAVROPOL STATE MEDICAL UNIVERSITY   (Russian Federation)

more..

Author keywords

Antimicrobial resistance; Nosocomial infections; Staphylococcus aureus

Indexed keywords

ANTIBIOTIC AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; GLYCOPEPTIDE; LEVOFLOXACIN; LINCOMYCIN; LINEZOLID; MOXIFLOXACIN; OXACILLIN; PSEUDOMONIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

AGAR MEDIUM; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONTROLLED STUDY; GEOGRAPHIC DISTRIBUTION; HOSPITAL INFECTION; NONHUMAN; PROSPECTIVE STUDY; RUSSIAN FEDERATION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

EID: 20944437648     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2005.17.1.54     Document Type: Article

References (21)

1. th ed. Philadelphia: Elsevier, 2005: 2321-51.
2. Rennie RP, Jones RN, Mutnick AH. Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis 2003; 45:287-93.
3. Hoban DJ, Biedenbach DJ, Mutnick AH, Jones RN. Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalised patients in North America: results of the SENTRY antimicrobial surveillance study. Diagn Microbiol Infect Dis 2003; 45:279-85.
4. Deshpande LM, Fritsche TR, Jones RN. Molecular epidemiology of selected multidrug-resistant bacteria: a global report from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis 2004; 49:231-6.
5. Ellis MW, Hospenthal DR, Dooley DP, Gray PJ, Murray CK. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis 2004; 39:971-9.
6. Charlebois ED, Perdreau-Remington F, Kreiswirth B, et al. Origins of community strains of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2004; 39:47-54.
7. Gosbell IB, Mercer JL, Neville SA, Chant KG, Munro R. Community-acquired, non-multiresistant oxacillin-resistant Staphylococcus aureus (NORSA) in south western Sydney. Pathology 2001; 33(2):206-10.
8. Mutnick AH, Enne V, Jones RN. Linezolid resistance since 2001: SENTRY antimicrobial surveillance program. Ann Pharmacother 2003; 37:909-11.
9. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; Fourteenth informational supplement. NCCLS Document M100-S13. 2004; 24(1).
10. Comite De L'Antibiogramme De La Societe Francaise De Microbiologie. Report 2000-2001. Available at url: www.sfm.asso.fr/
11. Finlay JE, Miller LA, Poupard JA. Interpretive criteria for testing susceptibility of staphylococci to mupirocin. Antimicrob Agent Chemother 1997; 41:1137-1139.
12. Metallidis S., Chatzidimitriou M., Nikolaidis P. Comparative in vitro activity of linezolid and five other antimicrobials against nosocomial isolates of methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium. J Chemother 2003; 15:442-8.
13. Fluit AC, Wielders CL, Verhoef J, Schmitz F-J. Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolated from 25 university hospitals participating in the European SENTRY study. J Clin Microbiol 2001; 39:3727-32.
14. Tiemersma EW, Bronzwaer SL, Lyytikäinen O, et al. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis 2004; 10: 1627-34.
15. Samra Z, Gadba R, Ofir O. Antibiotic susceptibility and phage typing of methicillin-resistant and sensitive Staphylococcus aureus clinical isolates at the period during 1991-1997. Eur J Clin Microbiol Infect Dis 2001; 20:427-7/
16. O'Neill AJ, Cove JH, Chopra I. Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus. J Antimicrob Chemother 2001; 47:647-50.
17. Schmitz F-J, Fluit AC, Hafner D, et al. Development of resistance to ciprofloxacin, rifampin, and mupirocin in methicillin-susceptible and -resistant Staphylococcus aureus isolates. Antimicrob Agent Chemother 2000; 44:3229-31.
18. Kochman M, Fordymacki P, Lawrynowicz-Pacior M, et al. Susceptibility to selected chemotherapeutics Staphylococcus aureus strains resistant to methicillin isolated from clinical materials in the years 1991-1992 and 1997. Med Dosw Microbiol 1999; 51(3-4):187-98.
19. Kresken M, Hafner D, Schmitz FJ, Wichelhaus TA. Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis: results of the Antimicrobial Resistance Surveillance Study of the Paul-Ehrlich-Society for Chemotherapy. Int J Antimicrob Agents 2004; 23:577-81.
20. Nishijima S, Kurokawa I. Antimicrobial resistance of Staphylococcus aureus isolated from skin infections. Int J Antimicrob Agents 2002; 19:241-3.
21. Hamilton-Miller JMT, Shah S. Patterns of phenotypic resistance to the macrolides-lincosamide-ketolide-streptogramin group of antibiotics in staphylococci. J Antimicrob Chemother 2000; 46:941-949.